Skip to main content

Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    dipeptidyl peptidase-4 (DPP-4) inhibitor
    sodium-glucose cotransporter-2 (SGLT-2) inhibitor
    sulfonylurea
    Health Outcome(s)
    diabetes
    type 1 diabetes mellitus
    type 2 diabetes mellitus
    Description

    This report contains the estimated number of new users of Sodium/Glucose Cotransporter (SGLT-2) Inhibitors, Sulfonylureas, and Dipeptidyl peptidase-4 (DPP-4) Inhibitors among all users overall, users with Type I diabetes codes, and users with Type II diabetes codes.

    Additional Details
    FDA Center
    CDER
    Time Period
    April 1, 2013 - September 30, 2015
    Analysis Type
    Descriptive
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)